Position in TLX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$180,075
New position
Shares Held
15,618
first reported quarter
Ownership
0.005%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#28
of 62 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 63%
Shared 0%
None 37%
Position in Biotechnology
Healthcare · as of Jun 30, 2026Orion Porfolio Solutions, LLC holds $66,105,110 across 61 Biotechnology names. TLX ranks #55 (0.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
11,853 | $5,887,740 | |
| 2 | JAZZ |
Jazz Pharmaceuticals plc
|
23,454 | $5,651,710 | |
| 3 | RPRX |
Royalty Pharma plc
|
99,319 | $5,568,816 | |
| 4 | INSM |
INSMED Inc
|
35,467 | $3,781,491 | |
| 5 | ARGX |
Argenx SE
|
2,471 | $2,292,519 | |
| 6 | INVA |
Innoviva, Inc.
|
92,707 | $2,105,375 | |
| 7 | IONS |
Ionis Pharmaceuticals Inc
|
24,870 | $1,971,942 | |
| 8 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
3,491 | $1,874,492 |
All Filings in TLX
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $180,075 | 15,618 | Shares | Sole | 2026-08-14 | |
| No filing history on record for this holder in this stock. | ||||||